Also interesting
UCB invests in a bioproduction plant in Braine-l’Alleud
To support the launch of a new generation of products, UCB, the biopharmaceutical company specialized in neurology and immunology, is investing 300 million euros in the construction of an ultra-modern biological production plant at its site in Braine-l’Alleud...
Kaneka Eurogentec receives GMP accreditation for its new state-of-the-art facility in time for the production of DNA vaccines against COVID-19
The new facility audited and certified by Belgian Authorities is equipped with a 2200 L fermenter and is ready to start operating from this summer. It will
Univercells writes a new biomanufacturing chapter with Africa
Discover how Belgian biotech company Univercells Group intends to make vaccines accessible for everyone in Africa.